|Go to market news section|
7 December 2012
e2v technologies PLC
e2v announces contract renewal
Consistent with our last half yearly report, e2v is announcing the agreement of a new multi-year contract with Accuray Incorporated, based in Sunnyvale, California US, for the supply of compact modulators and magnetrons for incorporation into Accuray's TomoTherapy® Hi-Art® Systems, used for the treatment of cancer.
The contract is effective 1st November 2012 and covers a 5 year period for the exclusive supply of magnetrons and a 3 year period for the supply of compact modulators. The combined contract will be worth a minimum of £20m.
e2v's compact modulators and magnetrons represent critical technology within the TomoTherapy Hi-Art System, providing the microwave power which is converted into X-rays for the imaging and radiation treatment of tumours.
The magnetrons supplied will be used in new systems and for the ongoing support of the installed base.
e2v technologies plc Tel: +44 (0)1245 493 493
Keith Attwood, Chief Executive
Charles Hindson, Group Finance Director
Pelham Bell Pottinger Tel: +44 (0)20 7861 3232
e2v is a leading global provider of specialist technology for high performance systems and equipment; delivering solutions, sub-systems and components for specialist applications within medical & science, aerospace & defence, and commercial & industrial markets.
e2v has its headquarters in the UK, employs approximately 1650 people, has design and production facilities across Europe and North America, and has a global network of sales and technical support offices. For the year ended 31 March 2012, e2v reported sales of GBP235m and is listed on the London Stock Exchange.
For more information visit e2v.com
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.
|©London Stock Exchange plc. All rights reserved|